Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Eli Lilly to Acquire Centessa Pharmaceuticals for $6.3 Billion
Eli Lilly and Company announced on March 31 that it will be acquiring Boston- and London-based Centessa Pharmaceuticals. Centessa Pharmaceuticals is a clinical-stage pharmaceutical company developing a new class of drugs for the treatment of excessive daytime sleepiness and other neurological conditions. Centessa’s lead program is cleminorexton, formerly known as ORX750, which is undergoing a phase 2 study for two types of narcolepsy as well as idiopathic hypersomnia. Eli Lilly is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Eli Lilly discovers, develops, manufactures and sells pharmaceutical products worldwide. Its products... Read More »
Sidelined Capital: A Healthcare Webinar Wrap Up
Earlier in March, Ben Swett, Managing Editor of The SeniorCare Investor, was joined by John Tiedmann, Managing Director at Physician Growth Partners, Bill Hoffman, Shareholder at Polsinelli and Matt Bogle, Managing Director at Intrinsic, to examine key factors fueling and impeding healthcare services M&A deal volume. In a follow-up to our previously posted webinar wrap-up, we’re discussing the panelists’ perspectives on the different healthcare verticals, their headwinds/tailwinds and impact on the market. BEHAVIORAL HEALTH Although the Behavioral Healthcare (BHC) market saw a leading 44% surge in activity from 2024 to 2025, deal volume still trailed expectations given the... Read More »A New Normal? Q1:26 Healthcare M&A Stalls
According to data captured in our LevinPro HC platform, healthcare M&A stalled in the first quarter of 2026, reaching only 527 deals, a modest 3% dip compared with the fourth quarter. The difference in volume is small enough to feel almost arbitrary, but these slight quarter-over-quarter variations have become the norm over the past 24 months. As you can see in the chart below, deal volume has remained remarkably stable, aside from outliers in Q1:25 and Q3:25, each with deal activity exceeding 550 transactions. Source: LevinPro HC, March 2026 The steady deal volume suggests that the headwinds and tailwinds from 2024 and 2025 continue to steer the market. We suspect one reason deal... Read More »
Collectly Acquires Pledge Health to Accelerate End-to-End RCM Automation
Collectly announced that it has completed the acquisition of Truckee, California-based Pledge Health for an undisclosed price. Pledge Health is an AI automation company focused on reducing repetitive administrative work across revenue cycle management (RCM) workflows. Pledge Health’s platform includes a visual AI agent builder that enables teams to automate core pre-service financial workflows. Collectly is an AI-powered technology company specializing in patient billing, revenue cycle management and engagement solutions. Trusted by more than 3,000 healthcare facilities, Collectly has processed more than $1 billion in patient payments. This acquisition accelerates end-to-end RCM... Read More »Merck to Buy Terns Pharmaceuticals for $6.7 Billion
Merck & Co., Inc., known as MSD outside the United States and Canada, will acquire Terns Pharmaceuticals Inc. for $53.00 per share in cash for an approximate equity value of $6.7 billion. Terns Pharmaceuticals Inc. is a clinical-stage oncology company based in San Mateo, California. Terns’ lead program, TERN-701, is a highly selective, oral, allosteric BCR:ABL1 inhibitor with a potentially best-in-disease profile that could meaningfully improve upon the efficacy, safety and convenience of existing treatments for chronic myeloid leukemia. Merck is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. Merck is focused on the discovery, development,... Read More »
Smile Partners USA Acquires Atlanta Endodontics
On March 24, Smile Partners USA announced that it was expanding its presence in Georgia with the acquisition of Atlanta Endodontics. Atlanta Endodontics, based out of one Atlanta, Georgia location, provides the full scope of endodontic services. It has three doctors on staff: Dr. Slosberg, Dr. Kanter and Dr. Cohen. Smile Partners USA is a management support organization backed by Silver Oak Services Partners. The company offers back-office resources and services to premier, independent private dental practices and boutique group practices throughout Michigan, Georgia, Illinois and Alabama. The financial terms were not disclosed. This... Read More »
SG Property Services Acquires Jacksonville, Florida Property
SG Property Services, based in Atlanta, Georgia, reported its second acquisition of the year with the purchase of Fleming Island Medical Plaza. The financial terms were not disclosed. Fleming Island Medical Plaza is a two-facility medical outpatient building (MOB) portfolio based in Jacksonville, Florida. The MOB comprises 82,790 square feet. Built in 2010 and 95% occupied, it offers a strong mix of primary care, orthopedics, imaging and women’s health providers. SG Property Services is a vertically-integrated real estate firm. The company was founded in 2010 and focuses on healthcare-oriented real estate and professional office development... Read More »
AngelEye Health Buys SupportSpot Platform from Child Life On Call
AngelEye Health announced on March 25 the acquisition of the SupportSpot platform from Austin, Texas-based Child Life On Call. The SupportSpot platform was developed by Child Life On Call, a digital platform dedicated to child life–informed psychosocial support and procedural preparation resources for pediatric patients and their families. AngelEye Health is a leading provider of tele-engagement solutions for hospital neonatal and pediatric units. AngelEye Health was founded by clinicians with the support of the University of Arkansas for Medical Sciences BioVentures. With this acquisition, AngelEye will expand its digital education offerings across both inpatient and post-discharge... Read More »
Vitality Global Acquires Ramp Health
Vitality Global will be acquiring Ramp Health for an undisclosed price, according to a March 25 press release. Ramp Health is a comprehensive, full-service risk mitigation provider that partners with employers, government agencies and insurers to improve employee health and safety, increase engagement and reduce healthcare and workers’ compensation costs. By combining a personalized digital platform with integrated onsite and virtual coaching and clinical services, Ramp delivers a holistic, end-to-end solution that differentiates it from traditional occupational health and digital-only vendors. Vitality Global is a health and wellness company active in 41 markets. More than 52 million... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
